Eligibility for vericiguat in a real‐world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry
暂无分享,去创建一个
L. Lund | P. Mol | U. Dahlström | G. Savarese | J. Ezekowitz | L. Benson | E. Imbalzano | G. Ferrannini | J. Butler | F. Lindberg | Ngoc V Nguyen | G. Rosano | Giuseppe M C Rosano